Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors
1370554-01-0
Chemical Name: 4-((4-(1H-tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole
1 Inhibitors of NEP have been shown to increase plasma levels of endogenous atrial natriuretic peptides and
fibroblast growth factor receptor 1
MDV-3100 - CAS# 915087-33-1 238 Pharmacokinetic dose-scheduling study of hedgehogEnzalutamide, also known as MDV3100, CAS No. 915087 33 1, is an orally bioavailable, organic, non steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, selective androgen receptor modulator MDV3100 inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation
US$ 194.00
US$ 182.00
US$ 123.00
US$ 93.00
US$ 250.00
US$ 55.00